Evidence map›Paper›PMID 42264880›Full record

ArticleBMJ open respiratory research2026

Describing the burden and characteristics of

Tim Venkatesan, Navjeet Nagi, Lisa Nwankwo, Darius Armstrong-James, Meg Coleman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tim VenkatesanImperial College Healthcare NHS Trust, London, England, UK tim.venkatesan@nhs.net.ORCID http://orcid.org/0000-0002-7733-2308
Navjeet NagiImperial College Healthcare NHS Trust, London, England, UK.
Lisa NwankwoPharmacy Department, Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, England, UK.
Darius Armstrong-JamesImperial College Healthcare NHS Trust, London, England, UK.
Meg ColemanImperial College Healthcare NHS Trust, London, England, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe epidemiology of

methodsElectronic health records were reviewed to identify individuals tested for serological markers of

resultsIn total, 334 individuals met criteria for serologic allergic bronchopulmonary aspergillosis (sABPA), 145 for ABPA, 74 for chronic pulmonary aspergillosis (CPA), 38 for simple aspergilloma and 11 with CPA-ABPA overlap. Serological responses varied: ABPA patients had higher median

conclusionsWhile case numbers are likely underestimated, our findings highlight a substantial and heterogeneous local burden. This improved understanding of local epidemiology will inform our local service development.

Indexed as

Aspergillosis, Allergic BronchopulmonaryPulmonary AspergillosisAdultAgedAntibodies, FungalAspergillus fumigatusChronic DiseaseFemaleHumansImmunoglobulin EImmunoglobulin GLondonMaleMiddle AgedRetrospective StudiesTomography, X-Ray ComputedAntibodies, FungalImmunoglobulin EImmunoglobulin GAspergillus Lung DiseaseAsthmaClinical EpidemiologyInfections

Identifiers

PMID42264880
PMCPMC13264950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.